NovaBay Pharmaceuticals Files 2024 10-K
Ticker: NBY · Form: 10-K · Filed: Apr 2, 2025 · CIK: 1389545
| Field | Detail |
|---|---|
| Company | Novabay Pharmaceuticals, INC. (NBY) |
| Form Type | 10-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
NovaBay dropped its 2024 10-K. Check financials.
AI Summary
NovaBay Pharmaceuticals, Inc. filed its 2024 10-K on April 2, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates in the pharmaceutical preparations sector. Its principal executive offices are located in Emeryville, California.
Why It Matters
This filing provides a comprehensive overview of NovaBay's financial performance, business operations, and risk factors for the fiscal year 2024, crucial for investors and stakeholders to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, NovaBay faces inherent risks related to drug development, regulatory approvals, market competition, and financial performance, which are detailed in its 10-K filing.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 20250402 — Filing Date (The date NovaBay Pharmaceuticals, Inc. submitted its 10-K to the SEC.)
Key Players & Entities
- NovaBay Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2000 POWELL STREET, SUITE 1150 (address) — Company's business and mailing address
- EMERYVILLE, CA (location) — City and State of company's address
- 20250402 (date) — Filing date of the 10-K
- 20241231 (date) — Fiscal year end date
FAQ
What is the primary business of NovaBay Pharmaceuticals, Inc.?
NovaBay Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations industry, SIC code 2834.
When did NovaBay Pharmaceuticals, Inc. file its 10-K report?
NovaBay Pharmaceuticals, Inc. filed its 10-K report on April 2, 2025.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Where is NovaBay Pharmaceuticals, Inc. headquartered?
NovaBay Pharmaceuticals, Inc. is headquartered at 2000 Powell Street, Suite 1150, Emeryville, CA 94608.
What is the SEC file number for NovaBay Pharmaceuticals, Inc.?
The SEC file number for NovaBay Pharmaceuticals, Inc. is 001-33678.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 2, 2025 regarding NovaBay Pharmaceuticals, Inc. (NBY).